ICS use safe in kids with asthma, no evidence of suppression of Hypothalamic-Pituitary-Adrenal Axis

Written By :  Dr. Kamal Kant Kohli
Published On 2023-07-11 01:00 GMT   |   Update On 2023-07-11 06:22 GMT

Jodhpur, Rajasthan: Inhaled corticosteroids are considered the most effective treatment for children with persistent asthma. However, adverse effects of ICS on the Hypothalamic Pituitary Adrenal axis, growth and bone metabolism are a concern.A recent study published in the Indian Journal of Pediatrics has suggested inhaled corticosteroids (ICS) to be a safe drug in children for asthma...

Login or Register to read the full article

Jodhpur, Rajasthan: Inhaled corticosteroids are considered the most effective treatment for children with persistent asthma. However, adverse effects of ICS on the Hypothalamic Pituitary Adrenal axis, growth and bone metabolism are a concern.

A recent study published in the Indian Journal of Pediatrics has suggested inhaled corticosteroids (ICS) to be a safe drug in children for asthma treatment, even for the long term.

The study showed that a few children had low post-adreno-corticotropic hormone (ACTH) stimulation cortisol value, and none had clinical evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression.

The study was conducted by Prawin Kumar, All India Institute of Medical Sciences (AIIMA), Jodhpur, Rajasthan, India, and colleagues to evaluate the effect of the long-term use of inhaled corticosteroids on the hypothalamic-pituitary-adrenal axis.

The study included children aged 5 to 18 years with asthma diagnosis and n ICS therapy for ≥6 months. Firstly, the screening with fasting was done at 8 AM; cortisol level was measured; <15 mcg/dl value was considered low. In the second step, children with low fasting cortisol were subjected to ACTH stimulation. Post-ACTH stimulation, cortisol level <18 mcg/dl was considered to have HPA axis suppression.

In the study, the researchers enrolled 78 children (males 55, 70.5%) diagnosed with asthma, with a median age of 11.5 years. The median duration of ICS use was 12 months.

The study led to the following findings:

  • The median value of post-ACTH stimulation cortisol level was 22.5 mcg/dl, and a value <18 mcg/dl was observed in 4 children.
  • There was statistically no significant correlation between low post-ACTH stimulation cortisol level with ICS dose and asthma control.
  • None of the children had clinical features of adrenal insufficiency.

"Our results showed that a few children had low post-ACTH stimulation cortisol values; however, none had clinical evidence of HPA axis clinical suppression," the researchers wrote. "Therefore, even for long-term use, ICS is a safe drug in children for treating asthma."

Reference:

Hema, L.S., Kumar, P., Goyal, J.P. et al. Effect of Long-term Inhaled Corticosteroids on the Hypothalamic-Pituitary-Adrenal Axis in Children with Asthma. Indian J Pediatr (2023). https://doi.org/10.1007/s12098-023-04706-6


Tags:    
Article Source : Indian Journal of Pediatrics

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News